logologo

Trending

Alerts

Newsletter

Search

Trending

Alerts

Newsletter

Log In

Sign Up

Uptrends.ai brand logo by Babbl
Uptrends TwitterUptrends InstagramUptrends LinkedinCommunity Discord
product
PricingHow it worksReviewsFeatured in
resources
BlogFAQsQuick startCommunityChange log
company
Explore CareersContact SupportContact SalesBecome a SponsorBecome an Affiliate ✨
© 2024 Babbl Labs, Inc.
Terms & conditions
Privacy policy

Mentions

Mentions

Mentions of this stock across all news source scraped in the past 30 days

Recent Mentions

Recent articles, blogs, and social posts pertaining to this stock

No data available

Company Logo

Ligand Pharmaceuticals

LGND

Biotech

Health Care

Pharma

+2

Country

US

Industry

Health Care

Market Cap

Small Cap

Num. Employees

76

IPO Date

Nov 18, 1992

LGND

Country

US

Industry

Health Care

Biotech

Health Care

+3


Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. The company is headquartered in San Diego, California and currently employs 76 full-time employees. The firm is focused on acquiring or funding programs and technologies that pharmaceutical companies use to discover and develop medicines. The Company’s Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Its Pelican Expression technology is a scalable platform for recombinant protein production, and is especially suited for complex, large-scale protein production. The Company’s products include Kyprolis, Teriparatide, Evomela, Rylaze, Nexterone, Pneumosil, Vaxneuvance, and Other. Kyprolis is formulated with Ligand’s Captisol technology. Teriparatide Injection is a drug indicated for uses including the treatment of osteoporosis in certain patients at high risk for fracture. Evomela is a Captisol-enabled melphalan IV formulation. Its other products include Pneumosil, Rylaze, Nexterone, Veklury, Zulresso, and Noxafil-IV.

Recent Mentions

Recent Mentions

Recent articles, blogs, and social posts pertaining to this stock

LGND

See sentiment for LGND and 5000+ other stocks

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Lorem Ipsum

•

Jan 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Lorem • Ipsum

Related Stocks

Related Stocks

Stocks being mentioned with LGND

DVAX

95% Match

Dynavax Technologies

$10.27

+1.38%

Very Bearish

CHRS

94% Match

Coherus BioSciences

$0.81

+1.78%

Very Bearish

BTAI

93% Match

BioXcel Therapeutics

$1.93

-2.53%

Very Bearish

IMVT

93% Match

Immunovant

$16.95

+0.59%

Very Bearish

QTRX

93% Match

Quanterix

$6.98

+1.90%

Very Bearish

AUPH

87% Match

Aurinia Pharmaceuticals

$7.59

+1.07%

Very Bearish

PFE

83% Match

Pfizer

$25.38

+0.12%

Very Bearish

News Events

News Events

Recent alerts triggered for LGND from the last 30 days


•


•


•


•


•


•


•


•